| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3283790 | Clinical Gastroenterology and Hepatology | 2009 | 5 Pages |
Abstract
Recent retrospective cohort data and a prospective randomized sham controlled trial have clearly documented the impact of endoscopic ablation therapy on dysplasia and Barrett's esophagus (BE). The clinical indications for ablation of BE includes high-grade dysplasia and intramucosal adenocarcinoma. The techniques of resection of mucosal irregularities and of ablation are reviewed, primarily thermal and photodynamic ablation. Ablation of BE with neoplasia has appropriately entered the clinical arena.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Richard E. Sampliner,